Pharma Update
Agenda
Welcome
10:30-10:35 BST Bruno Eschli, Head of Investor Relations
Group Update
-
10:35 11:05 BST Thomas Schinecker, CEO Roche Group
Pharma Update and On-Market Portfolio
11:05 - 11:40 BST Teresa Graham, CEO Roche Pharmaceuticals
Late Stage Pipeline Oncology (Solid Tumors)
11:40-12:00 BST Levi Garraway, CMO and Head Global of Product Development
12:00 12:50 BST Lunch Break
-
Late Stage Pipeline Hematology
12:50-13:05 BST Charles Fuchs, SVP Global Head of Oncology and Hematology Product Development
Late Stage Pipeline Neuroscience, Immunology and Cardiovascular-Metabolism
13:05 13:30 BST Paulo Fontoura, SVP and Global Head of Neuroscience and Immunology
Late Stage Pipeline Ophthalmology
13:30-13:45 BST Christopher Brittain, VP and Global Head of Ophthalmology Product Development
13:45-14:30 BST Q&A
14:30-15:00 BST Buffet reception
RocheView entire presentation